Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nematode muscle cell GABA-gated chloride channel, primarily encoded by the unc-49 gene, is a member of the Cys-loop ligand-gated ion channel superfamily [1, 6]. It is located at the neuromuscular junction of nematodes, where it mediates inhibitory neurotransmission by allowing chloride ions to flow across the muscle cell membrane [6, 12]. This process leads to muscle relaxation, which is essential for the characteristic sinusoidal locomotion of the worm [6, 12]. Because of its critical role in movement and its structural divergence from vertebrate GABA receptors, it is a major therapeutic target for anthelmintic drugs [1, 7]. Agonists such as piperazine induce flaccid paralysis in parasites, facilitating their expulsion from the host [1, 12]. Macrocyclic lactones like ivermectin can also modulate these channels, although their primary targets are typically glutamate-gated chloride channels [13, 17]. The receptor is composed of multiple subunits, such as UNC-49B and UNC-49C, which form functional heteromeric or homomeric channels [6, 17]. However, the emergence of drug resistance in various nematode species poses a significant challenge to the continued efficacy of treatments targeting this receptor [7, 14]. Understanding the pharmacological differences between nematode and mammalian GABA receptors is crucial for developing selective and safe anthelmintics [2, 4].
Agonists bind to the receptor, opening the chloride-selective pore and causing membrane hyperpolarization or shunting inhibition, which results in flaccid paralysis of the nematode body wall muscle.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UNC-49 GABA-gated chloride channel (UNC-49).